Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 3
1(16.7%)
6Total
N/A(5)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07127029Not ApplicableCompleted

Effect of Petrolatum Coating on Fast-absorbing Gut Suture

Role: lead

NCT03537534Phase 3Terminated

Intraurethral Lidocaine After Endourology Procedures

Role: lead

NCT06120829Not ApplicableUnknown

Cryobiopsy for Suspected Malignant Peripheral Lymphadenopathy

Role: lead

NCT03130907Not ApplicableCompleted

The Role of Ureteral Stenting Following Uncomplicated Ureteroscopy for Ureteral and Renal Stones: A Randomized, Controlled Trial

Role: lead

NCT03502889Not ApplicableUnknown

Single Dose Adductor Canal Block vs SPANK Block for TKA

Role: lead

NCT03625843Not ApplicableCompleted

Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing

Role: lead

NCT01028235Unknown

Routine Screening for Eosinophilic Esophagitis in Patients Presenting With Dysphagia

Role: lead

All 7 trials loaded